STOCK TITAN
  1. Home
  2. News
  3. IMCC

IM Cannabis Corp - IMCC STOCK NEWS

Welcome to our dedicated news page for IM Cannabis (Ticker: IMCC), a resource for investors and traders seeking the latest updates and insights on IM Cannabis.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect IM Cannabis's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of IM Cannabis's position in the market.

News
IMC to transfer its Oranim Pharmacy shares back to the seller
Rhea-AI Summary
IM Cannabis Corp. (IMCC) decides not to make remaining installment payments to IMC Holdings and will transfer back 51% shares. The company focuses on the German market post-cannabis legalization for growth potential.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.86%
Tags
none
-
News
IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market
Rhea-AI Summary
IM Cannabis Corp. (IMCC) forms a strategic distribution agreement with Vessel Brand Inc, a subsidiary of Flora Growth Corp., to enhance its presence in the Israeli medical cannabis market. The agreement aims to offer premium cannabis accessories through IMC's established distribution channels, including pharmacies and online platforms.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.23%
Tags
partnership
-
News
Avant and IMC Execute BLK MKT™ Trademark Licensing Agreement for the German Medical Cannabis Market
Rhea-AI Summary
IM Cannabis Corp. and Avant Brands Inc. sign a Licensing Agreement for the BLK MKT brand in the German medical cannabis market, aiming to capitalize on the recent legalization in Germany. The agreement enhances IMC's premium strategy in Germany and Israel, leveraging Avant's innovative cannabis products. IMC Germany, a subsidiary of IM Cannabis Corp., will exclusively utilize Avant's BLK MKT brand on medical cannabis products cultivated by Avant for the German market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.08%
Tags
none
News
Avant Brands Bolsters International Growth in German Cannabis Market Through Partnership with IMC
Rhea-AI Summary
Avant Brands Inc. and IM Cannabis Corp. sign an International Trademark Licensing Agreement for Avant's BLK MKT brand in the German cannabis market. The collaboration aims to leverage Avant's premium cannabis flower with IMC's sales and marketing strategies to capitalize on the growing German medical cannabis market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.08%
Tags
partnership
-
News
IMC applauds the April 1st implementation of the new Israeli cannabis regulation, facilitating access for many new patients
Rhea-AI Summary
IM Cannabis Corp. welcomes the implementation of medical cannabis regulatory reform in Israel, making it more accessible to new patients. The reform includes changes in the prescription process, allowing medical cannabis to be prescribed through HMO's, increasing the number of prescribing physicians, and reducing the cost of prescriptions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
40%
Tags
none
-
News
IM Cannabis Reports 2023 Financial Results
Rhea-AI Summary
IM Cannabis Corp. (IMCC) announces financial results for 2023, with a revenue decrease of 10% to $48.8 million, primarily due to negative currency fluctuations and the Israel-Hamas war impact. Gross profit increased by 7.5% to $9.8 million. G&A expenses decreased by 49% to $11 million. Net loss from continuing operations was $10.2 million for 2023. Cash and cash equivalents were $1.8 million as of December 31, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
28.92%
Tags
earnings
News
IMC Expects Accelerated Growth in Germany from the Country's Groundbreaking Cannabis Legalization
Rhea-AI Summary
IM Cannabis Corp. (IMCC) anticipates strong growth in the German medical cannabis market after the regulatory rescheduling of cannabis to a regular prescription. IMC Germany achieved 180% growth in 2023, surpassing market growth. The company is well-positioned with infrastructure, certifications, and supply agreements to capitalize on the evolving German market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.5%
Tags
none
-
News
IM Cannabis to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 28 at 9:00am ET
Rhea-AI Summary
IM Cannabis Corp. to report Q4 and full year 2023 financial results on March 28, 2024, hosting a web conference for investors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.64%
Tags
conferences earnings
-
News
IM Cannabis Receives 180 Calendar Day Extension from the Nasdaq Stock Market to Regain Compliance with Bid Price Rule
Rhea-AI Summary
IM Cannabis Corp. has received a 180-day extension from the Nasdaq Stock Market to regain compliance with the Bid Price Rule. The company will continue to monitor the closing bid price of its common stock and plans to pursue available options to regain compliance, including potentially pursuing a reverse stock split.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.09%
Tags
none
News
IMC Reschedules the Final Payment of the Oranim Pharmacy Acquisition
Rhea-AI Summary
IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) announces the rescheduling of the final payment for the Oranim Pharmacy Acquisition and reconciliation with parties regarding remaining transaction payments to April 15, 2024. The acquisition of 51% rights in Oranim Pharm Partnership was completed on March 28, 2022, with NIS 5,363K or 1,930K CAD to be paid in six installments throughout 2023, and the final payment was originally due on February 15, 2024. A new amendment signed on January 10, 2024, postpones the sixth payment and reconciliation to April 15, 2024, with a 15% interest charge on all remaining unpaid installments. Failure to meet the payments will result in the transfer of IMC Holdings Ltd. shares back to the seller and revocation of the transaction.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5%
Tags
acquisition
Stock IMCC logo
IM Cannabis Corp

Nasdaq:IMCC

IMCC Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

IMCC Stock Data

8.68M
8.59M
36.09%
8.15%
0.73%
Medicinal and Botanical Manufacturing
Manufacturing
Link
Israel
Tel Aviv

About IMCC

premium medical cannabis products for global consumers – im cannabis (imc) is one of the world's pioneering medical-grade cannabis companies, with operations in israel, across europe, and canada. over the past decade, imc has established its premium medical cannabis brand, comprising a full spectrum of products known for their quality, consistency, and purity, such as 'roma', 'tel aviv' and 'london'. in europe, imc has established a fully operational, vertically integrated medical cannabis business, spearheaded by its eu-gmp certified distribution arm in germany and augmented by strategic alliances with certified pan-eugmp certified suppliers. to this end, imc has formed strong strategic alliances within the international medical cannabis industry, aiming for a dominant position in satisfying the global demand for high-quality medical cannabis products, which both physicians and patients can rely upon. imc further intends to leverage its expertise in israel in order to bolster its res